MedPath

Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General Anesthesia

Phase 4
Conditions
General Anesthesia
Coughing Response
Thyroid Surgery
Interventions
Drug: Dexmeditomidine
Drug: normal saline
Registration Number
NCT02613806
Lead Sponsor
First Affiliated Hospital of Chongqing Medical University
Brief Summary

Coughing is a common adverse reaction of thyroid surgery,which could result in postoperative bleeding.Postoperative bleeding is a serious and potentially life-threatening complication,which could result in acute upper airway obstruction due to neck hematoma and increase the need for re-operation.The purpose of this study is to investigate whether dexmedetomidine can reduce the incidence of postoperative coughing and contribute to postoperative recovery in patients undergoing tyroid surgery with general anesthesia.

Detailed Description

Thyroid surgery is a common clinical surgery,the incidence of postoperative coughing is up to 32.4%.Coughing response could result in postoperative bleeding,even cause respiratory tract obstruction,affect patients' postoperative recovery .Dexmedetomidine,an α2 adrenergic agonist,has hypnotic,analgesic, anxiolytic,antisympathetic effects,which could facilitate the sedation of patients while maintaining their consciousness and keep respiration and circulation stable .For these benefits,dexmedetomidine was widely used for general anesthesia.However,whether dexmedetomidine can reduce the incidence of postoperative coughing is unclear.Therefore,the investigators conduct this randomized controlled double-blind trial,to investigate the effects of dexmedetomidine on coughing and postoperative recovery quality in patients undergoing tyroid surgery with general anesthesia.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
118
Inclusion Criteria
  1. Aged from 18 to 65 years old
  2. American Society of Anesthesiologists (ASA) physical statusⅠor Ⅱ
  3. Diagnosed by B ultrasonic or tissue biopsy show that patients thyrophyma,thyroid cancer,thyroid nodule,etc,who need to accept thyroid surgery
Exclusion Criteria
  1. large goiter or hyperthyroidism
  2. Preoperative coughing caused by primary diseases of patients
  3. Ⅱdegrees above atrioventricular block
  4. Allergy to anesthesia
  5. History of diabetes
  6. Pregnant women
  7. Serious mental disease
  8. History of alcohol or drug abuse
  9. Severe heart renal or liver dysfunction
  10. The presence of an upper respiratory infection
  11. Asthma
  12. Anticipated difficult airway

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
D group (dexmedetomidine)DexmeditomidineDexmeditomidine 0.2 ug/kg·h will be administered to participants by intravenous infusion with microperfusion pump at the beginning of the surgery,and continued till end of surgery.
C group (saline)normal salineThe patients received equal volume normal saline by intravenous infusion at the beginning of the surgery,and continued till end of surgery.
Primary Outcome Measures
NameTimeMethod
the incidence of coughingwithin 48 hours postoperatively

coughing will be observed

Secondary Outcome Measures
NameTimeMethod
the time of extubationwithin 48 hours postoperatively

the time of extubation will be recorded

visual analogue scale (VAS)at 30 minutes after extubation

visual analogue scale will be measured at 30 minutes after extubation

coughing on a four-point scalewithin 48 hours postoperatively

coughing on a four-point scale will be measured within 48 hours postoperatively

the eyes opening timewithin 48 hours postoperatively

the eyes opening time will be observed

sedation-agitation scale(SAS)at 30 minutes after extubation

sedation-agitation scale will be measured at 30 minutes after extubation

Trial Locations

Locations (1)

The First Affliated Hospital of Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

© Copyright 2025. All Rights Reserved by MedPath